|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 15-08-04 | Hospira : Pfizer wins EU approval for $15 billion Hospira buy | RE |
| 15-07-27 | Allergan : Mylan independence from Teva's embrace comes with a price | RE |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | - | - | - | 0 | |
| 0.88% | 1.02% | 35.87x | 5.03x | 6.74x | 23.34x | 28.23x | 48.9B | |
| 1.34% | 1.42% | 19.3x | 1.97x | 2.27x | 10.33x | 13.46x | 40.42B | |
| 0.58% | 0.63% | 29.03x | 3.98x | 4.11x | 16.91x | 23.69x | 12.6B | |
| 0.89% | 1.01% | 28.48x | 3.15x | 3.47x | 17.99x | 23.06x | 12.39B | |
| 3.86% | 3.94% | 18.7x | 3.24x | 3.32x | 11.56x | 13.77x | 9.07B | |
| 4.41% | 5.13% | 9.13x | 1.57x | 2.11x | 5.49x | 6.77x | 7.53B | |
| 3.24% | 3.21% | 15.9x | 1.29x | 2.06x | 6.43x | 9.68x | 7.13B | |
| 0.23% | 0.17% | 34.76x | 6.15x | 3.96x | 16.87x | 18.63x | 6.78B | |
| 0.94% | 0.94% | 42.23x | 9.71x | 8.1x | 30.02x | 33.52x | 4.64B | |
| 1.83% | 1.73% | 14.76x | 0.72x | 2.06x | 8.81x | 11.14x | 4B | |
| 3.37% | 3.88% | 15.78x | 2.58x | 2.55x | 11.87x | 11.51x | 4B | |
| 2.68% | 2.75% | 14.79x | 2.98x | 3.44x | 12.86x | 14.21x | 2.94B | |
| 3.16% | 3.52% | 19.03x | 5.1x | 5.93x | 16.86x | 18.24x | 2.64B | |
| Average | 2.11% | 2.26% | 22.90x | 3.65x | 3.86x | 14.57x | 17.38x | 11.64B | |
| Weighted average by Cap. | 1.53% | 1.66% | 26.08x | 3.60x | 4.20x | 15.98x | 19.73x |
- Stock Market
- Stocks
- Stock
- Sector Hospira, Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
